Effective preparation of O-succinimidyl-2(tert- butoxycarbonylamino)ethylcarbamate derivatives from β-amino acids. Application to the synthesis of urea-containing pseudopeptides and oligoureas

Journal of Organic Chemistry

Volumn 64, Issue 23, 1999, Pages 8702-8705

  Guichard, Gilles ^a   Semetey, Vincent ^a   Didierjean, Claude ^b   Aubry, André ^b   Briand, Jean Paul ^a   Rodriguez, Marc ^c  

^a INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c Neosystem   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMIC ACID DERIVATIVE; PSEUDOPEPTIDE; SUCCINIMIDE DERIVATIVE; UREA DERIVATIVE;

ARTICLE; CHEMICAL REACTION; CHEMICAL STRUCTURE; CRYSTALLIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PROTON NUCLEAR MAGNETIC RESONANCE; SYNTHESIS;

EID: 0033550306     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo990092e     Document Type: Article

References (30)

1. (a) Lam, P. Y.; Jadhav, P. K.; Eyermann, C. J.; Hodge, C. N.; Ru, Y.; Bacheler, L. T.; Meek, J. L.; Otto, M. J.; Rayner, M. M.; Wong, Y. N.; Chang, C.-H.; Weber, P. C.; Jackson, D. A.; Sharpe, T. R.; Erickson-Viitenen, S. Science 1994, 263, 380.
2. (b) Castro, J. L.; Ball, R. G.; Broughton, H. B.; Russell, M. G. N.; Rathbone, D.; Watt, A. P.; Baker, R.; Chapman, K. L.; Fletcher, A. E.; Patel, S.; Smith, A. J.; Marshall, G. R.; Ryecroft, W.; Matassa, V. G. J. Med. Chem. 1996, 39, 842.
3. (c) von Geldern, T. W.; Kester, J. A.; Bal, R.; Wu-Wong, J. R.; Chiou, W.; Dixon, D. B.; Opgenorth, T. J. J. Med. Chem. 1996, 39, 968.
4. (a) Nowick, J. S.; Smith, E. M.; Noronha, G. J. Org. Chem. 1995, 60, 7386.
5. (b) Nowick, J. S.; Mahrus, S.; Smith, E. M.; Ziller, J. W. J. Am. Chem. Soc. 1996, 118, 1066.
6. (c) Nowick, J. S.; Holmes, D. L.; Mackin, G.; Noronha, G.; Shaka, A. J.; Smith, E. M. J. Am. Chem. Soc. 1996, 118, 2764.
7. (d) Holmes, D. H.; Smith, E. M.; Nowick, J. S. J. Am. Chem. Soc. 1997, 119, 7665.
8. (a) Burgess, K.; Linthicum, D. S.; Shin, H. Angew. Chem., Int. Ed. Engl. 1995, 34, 907.
9. (b) Burgess, K.; Ibarzo, J.; Linthicum, D. S.; Russell, D. H.; Shin, H.; Shitangkoon, A.; Totani, R.; Zhang, A. J. J. Am. Chem. Soc. 1997, 119, 1556.
10. (c) Kim, J.-M.; Bi, Y.; Paikoff, S. J.; Schultz, P. G. Tetrahedron Lett. 1996, 37, 5305.
11. (d) Kim, J.-M.; Wilson, T. E.; Norman, T. C.; Schultz, P. G. Tetrahedron Lett. 1996, 37, 5309.
12. (e) Kruijtzer J. A. W.; Lefeber, D. J.; Liskamp, R. M. J. Tetrahedron Lett. 1997, 38, 5335.
13. (f) Wilson, M. E.; Nowick, J. S. Tetrahedron Lett. 1998, 39, 6613.
14. For use of phosgene and its derivatives, see: (a) Majer, P.; Randad, R. S. J. Org. Chem. 1994, 59, 1937. (b) Scialdone, M. A.; Shuey, S. W.; Soper, P.; Hamuro, Y.; Burns, D. M. J. Org. Chem. 1998, 63, 4802-4807. For use of various carbonates, see: (c) Takeda, K.; Akagi, Y.; Saiki, A.; Tsukahara, T.; Ogura, H. Tetrahedron Lett. 1983, 24, 4569. Izdebski, J.; Pawlak, D. Synthesis 1989, 423. For use of N,N′- carbonyldiimidazole, see: (d) Zhang, X.; Rodrigues, J.; Evans, L.; Hinckle, B.; Ballantyne, L.; Pena, M. J. Org. Chem. 1997, 62, 6420.
15. For use of phosgene and its derivatives, see: (a) Majer, P.; Randad, R. S. J. Org. Chem. 1994, 59, 1937. (b) Scialdone, M. A.; Shuey, S. W.; Soper, P.; Hamuro, Y.; Burns, D. M. J. Org. Chem. 1998, 63, 4802-4807. For use of various carbonates, see: (c) Takeda, K.; Akagi, Y.; Saiki, A.; Tsukahara, T.; Ogura, H. Tetrahedron Lett. 1983, 24, 4569. Izdebski, J.; Pawlak, D. Synthesis 1989, 423. For use of N,N′- carbonyldiimidazole, see: (d) Zhang, X.; Rodrigues, J.; Evans, L.; Hinckle, B.; Ballantyne, L.; Pena, M. J. Org. Chem. 1997, 62, 6420.
16. For use of phosgene and its derivatives, see: (a) Majer, P.; Randad, R. S. J. Org. Chem. 1994, 59, 1937. (b) Scialdone, M. A.; Shuey, S. W.; Soper, P.; Hamuro, Y.; Burns, D. M. J. Org. Chem. 1998, 63, 4802-4807. For use of various carbonates, see: (c) Takeda, K.; Akagi, Y.; Saiki, A.; Tsukahara, T.; Ogura, H. Tetrahedron Lett. 1983, 24, 4569. Izdebski, J.; Pawlak, D. Synthesis 1989, 423. For use of N,N′- carbonyldiimidazole, see: (d) Zhang, X.; Rodrigues, J.; Evans, L.; Hinckle, B.; Ballantyne, L.; Pena, M. J. Org. Chem. 1997, 62, 6420.
17. For use of phosgene and its derivatives, see: (a) Majer, P.; Randad, R. S. J. Org. Chem. 1994, 59, 1937. (b) Scialdone, M. A.; Shuey, S. W.; Soper, P.; Hamuro, Y.; Burns, D. M. J. Org. Chem. 1998, 63, 4802-4807. For use of various carbonates, see: (c) Takeda, K.; Akagi, Y.; Saiki, A.; Tsukahara, T.; Ogura, H. Tetrahedron Lett. 1983, 24, 4569. Izdebski, J.; Pawlak, D. Synthesis 1989, 423. For use of N,N′- carbonyldiimidazole, see: (d) Zhang, X.; Rodrigues, J.; Evans, L.; Hinckle, B.; Ballantyne, L.; Pena, M. J. Org. Chem. 1997, 62, 6420.
18. For use of phosgene and its derivatives, see: (a) Majer, P.; Randad, R. S. J. Org. Chem. 1994, 59, 1937. (b) Scialdone, M. A.; Shuey, S. W.; Soper, P.; Hamuro, Y.; Burns, D. M. J. Org. Chem. 1998, 63, 4802-4807. For use of various carbonates, see: (c) Takeda, K.; Akagi, Y.; Saiki, A.; Tsukahara, T.; Ogura, H. Tetrahedron Lett. 1983, 24, 4569. Izdebski, J.; Pawlak, D. Synthesis 1989, 423. For use of N,N′-carbonyldiimidazole, see: (d) Zhang, X.; Rodrigues, J.; Evans, L.; Hinckle, B.; Ballantyne, L.; Pena, M. J. Org. Chem. 1997, 62, 6420.
19. For use of 1,1′-carbonylbisbenzotriazole, see: (e) Katritzky, A. R.; Pleynet, D. P. M.; Yang, B. J. Org. Chem. 1997, 62, 4155.
20. (a) Nowick, J. S.; Powell, N. A.; Nguyen, T. M.; Noronha, G. J. Org. Chem. 1992, 57, 7364.
21. (b) Reference 3b.
22. (a) Martinez, J.; Oiry, J.; Imbach, J.-L.; Winternitz, F. J. Med. Chem. 1982, 25, 178.
23. (b) Hutchins, S. M.; Chapman, K. T. Tetrahedron Lett. 1994, 35, 4055.
24. (c) Thavonekham, B. Synthesis 1997, 1189.
25. 1,3-Dihydro-2H-benzimidazol-2-ones and related compounds represent attractive families of building blocks having interesting biochemical and pharmacological properties. Regioselective alkylation of 1,3-dihydro-2H-benzimidazol-2-one and structurally related cyclic urea analogues was reported by Meanwell et al. through the use of monoalkoxycarbonyl derivatives (including compound 5). In this paper, 5 was synthesized by treatment of 1,3-dihydrobenzimidazol-2-one with NaH followed by an excess of di-tert-butyl dicarbonate. Meanwell, N. A.; Sit, S. Y.; Gao, J.; Wong, H. S.; Gao, Q.; St Laurent, D. R.; Balasubramanian, N. J. Org. Chem. 1995, 60, 1565.
26. It is noteworthy that for the synthesis of oligoanthranilamides the group of Hamilton used 2-nitrobenzoic acid in place of N-benzoylanthranilic acid. In this case, the nitro group as a masked form of the amine was required to avoid the formation of azlactone: Hamuro, Y.; Geib, S. J.; Hamilton, A. D. J. Am. Chem. Soc. 1996, 118, 7529.
27. 3-i-Pr (9).
28. (a) Podlech, J.; Seebach, D. Liebigs Ann. 1995, 1217.
29. (b) Seebach, D.; Overhand, M.; Kühnle, F. N. M.; Martinoni, B.; Oberer, L.; Hommel, U.; Widmer, H. Helv. Chim. Acta 1996, 79, 913.
30. Spatola, A. F. In Chemistry and Biochemistry of Amino Acids, Peptides and Proteins; Weinstein, B., Ed.; Marcel Dekker Inc.: New York, 1983; Vol. 7, pp 267-357.